Organon’s JADA System reaches efficacy endpoint in published study

Organon announced that Obstetrics & Gynecology, the peer-reviewed journal of the American College of Obstetrics and Gynecology, published the results of the RUBY study which reached its primary effectiveness outcome of successfully treating abnormal postpartum uterine bleeding and postpartum hemorrhage – PPH – with the JADA System. JADA is an intrauterine vacuum-induced hemorrhage control device intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. JADA achieved treatment success in both the vaginal – 92.5% – and cesarean birth – 83.7% – groups, regardless of the cause of the abnormal postpartum uterine bleeding. When reviewing patient cases that received standard PPH interventions plus the JADA System, lower blood loss prior to device insertion was associated with lower severe maternal morbidity.